Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/04/1995 | EP0674512A1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries |
10/04/1995 | EP0674510A1 Injectable composition |
10/04/1995 | EP0674507A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
10/04/1995 | EP0674506A1 Controlled release growth hormone containing microspheres |
10/04/1995 | EP0674497A1 Microporous macrocapsules |
10/04/1995 | EP0635040A4 Crosslinked biocompatible encapsulation compositions and methods. |
10/04/1995 | EP0592446B1 Loading technique for preparing drug containing liposomes |
10/04/1995 | CN1109364A Insulin formulation |
10/04/1995 | CN1109362A Powder good for bile |
10/04/1995 | CN1109361A Capsule for curing cystic hyperplasia of breast |
10/04/1995 | CN1109360A medicine for preventing and curing inflammation of mouth cavity and throat |
10/04/1995 | CN1109355A Expelling wind and analgesia ointment and its preparing method |
10/04/1995 | CN1109353A Prescription for defatting and hypotensor capsule and its making method |
10/04/1995 | CN1109350A Skin medicine |
10/04/1995 | CN1109348A Anti-senility and health instant powder and its producing method |
10/04/1995 | CN1109347A Anti-inflammatory spongy embolus |
10/04/1995 | CN1109343A High efficiency sterilizing ointment for women |
10/04/1995 | CN1109335A Medicine for curing mental disease and its preparing method |
10/04/1995 | CN1109329A Preparation for beta-carotene or carotene micro capsule and its application thereof |
10/04/1995 | CN1109328A Sustained release formulations for 24 hour release of metoprolol |
10/04/1995 | CN1109327A Active calcium special tablet and its preparing method |
10/04/1995 | CN1109326A Fuguiqin hydrochloride injection |
10/04/1995 | CN1109325A Wart ointment |
10/04/1995 | CN1109324A Producing method for traditional Chinese medicine frostlike-powder |
10/03/1995 | US5455342 Method and apparatus for the modification of starch and other polymers |
10/03/1995 | US5455286 Bioactive composition |
10/03/1995 | US5455279 Regimen method of mediating neuronal damage using nitroglycerine |
10/03/1995 | US5455270 Stabilized solutions of platinum(II) antitumor agents |
10/03/1995 | US5455240 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
10/03/1995 | US5455168 α-glycosyl trehalose-forming enzyme |
10/03/1995 | US5455049 Terfenadine oral powder |
10/03/1995 | US5455048 Sun filter microcapsules |
10/03/1995 | US5455047 Direct compression cholestyramine tablet and solvent-free coating therefor |
10/03/1995 | US5455046 Includes a heteropolysaccharide gum and a homopolysaccharide gum capable of crosslinking |
10/03/1995 | US5455045 High dose formulations |
10/03/1995 | US5455044 Release of therapeutic agent into cerebrospinal fluid |
10/03/1995 | US5455043 Device for controlled release of vaporous medications through nasal route |
10/03/1995 | US5455042 Ointment comprising a homogenous mixture of a polymer or copolymer of N-vinylacetamide, water and/or alcohols, and a pharmacologically active component |
10/03/1995 | US5455041 Method for inducing periodontal tissue regeneration |
10/03/1995 | US5455039 Administering a biocompatible polymer based heptarin releasing system |
10/03/1995 | CA2001395C Noningestible separation barrier with plugged pores |
09/29/1995 | CA2145584A1 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
09/29/1995 | CA2145579A1 Eva-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
09/28/1995 | WO1995025807A1 Inhibition of arterial smooth muscle cell proliferation |
09/28/1995 | WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
09/28/1995 | WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
09/28/1995 | WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
09/28/1995 | WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β) |
09/28/1995 | WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
09/28/1995 | WO1995025764A1 Double-stranded derivative of polyoxyethylene-containing lipid |
09/28/1995 | WO1995025736A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
09/28/1995 | WO1995025546A1 Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product |
09/28/1995 | WO1995025544A1 Gel for treatment of skin diseases and for disinfection of the skin |
09/28/1995 | WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
09/28/1995 | WO1995025534A1 Stabilized composition for oral administration of peptides |
09/28/1995 | WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
09/28/1995 | WO1995025526A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
09/28/1995 | WO1995025523A1 Novel pharmaceutical composition for skin diseases |
09/28/1995 | WO1995025521A1 Solid dose forms containing bismuth |
09/28/1995 | WO1995025518A1 Aqueous solution of levocabastine for ophthalmic use |
09/28/1995 | WO1995025516A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant |
09/28/1995 | WO1995025512A1 Process for making solid dose forms containing bismuth |
09/28/1995 | WO1995025509A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
09/28/1995 | WO1995025506A1 Multilayered controlled release pharmaceutical dosage form |
09/28/1995 | WO1995025505A1 Hydrophobic drug delivery systems |
09/28/1995 | WO1995025504A1 Emulsified drug delivery systems |
09/28/1995 | WO1995025502A1 Polyglycerine polyricinoleates |
09/28/1995 | WO1995023586A3 Cosmetic and/or pharmaceutical preparations |
09/28/1995 | CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
09/28/1995 | CA2186045A1 Gel for treatment of skin diseases and for disinfection of the skin |
09/28/1995 | CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
09/28/1995 | CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
09/28/1995 | CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.) |
09/28/1995 | CA2184200A1 Recombinant viruses, preparation and use in genic therapy |
09/27/1995 | EP0673857A2 Device for delivering an aerosol |
09/27/1995 | EP0673650A1 Pharmaceutical sustained-release dosage forms containing alfusozine hydrochloride |
09/27/1995 | EP0673649A1 Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration |
09/27/1995 | EP0673648A1 Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate |
09/27/1995 | EP0673647A1 Dermatological composition containing lactic acid salt |
09/27/1995 | EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases |
09/27/1995 | EP0673645A2 Pharmaceutical composition |
09/27/1995 | EP0673644A1 Process and plant for preparation of effervescent granules |
09/27/1995 | EP0673403A1 Composition, apparatus and method for providing a supply of water-based cool mixture. |
09/27/1995 | EP0673356A1 Chlorofluoroether compositions and preparation thereof |
09/27/1995 | EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor |
09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
09/27/1995 | EP0673253A1 Antacid composition and method of production |
09/27/1995 | EP0673250A1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
09/27/1995 | EP0673245A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same. |
09/27/1995 | EP0673244A1 System for dispensing pharmaceutically active compounds |
09/27/1995 | EP0673243A1 Improving effectiveness of drugs. |
09/27/1995 | EP0673242A1 Smooth muscle chemical pacemaker |
09/27/1995 | EP0673241A1 A free radical quenching liposomal composition |
09/27/1995 | EP0673240A1 Stabilized medicinal aerosol solution formulations |
09/27/1995 | EP0673239A1 Aqueous antibiotic composition for veterinary use |
09/27/1995 | EP0673236A1 Method for stimulating production of heme oxygenase using vitamin b12 |
09/27/1995 | EP0616525B1 Pharmaceutical aerosol formulation |
09/27/1995 | EP0578768B1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
09/27/1995 | CN1108968A Use of ion exchange resins loaded with quioolonecarboxylic acid derivatives |
09/27/1995 | CN1108952A Xiaokelin capsule for diabetes |